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Kathryn B. Garber1,*To Screen or Not to Screen for Maternal
Hypothyroidism
Because maternal hypothyroidism has been associated
with reduced cognitive abilities in children, it makes sense
that many obstetricians screen pregnant women for
thyroid function. On the other hand, there is a lack of
good evidence from randomized controlled trials that
population-based screening and subsequent management
to improve thyroid function has an effect. A large random-
ized screening trial recently published by Lazarus et al.
aimed to settle this issue, but it didn’t quite succeed.
Although the study did not find evidence to support pop-
ulation screening for maternal hypothyroidism, it also
didn’t rule out its potential utility. In this study, they
compared the intelligence quotients (IQs) of 3-year-old
children born to women who were screened and treated
for hypothyroidism to those of children whose mothers
were not screened; they could not find a significant differ-
ence between the two groups. As discussed in the accompa-
nying editorial by Gregory Brent, the women in this study
generally had fairly mild hypothyroidism, which might
not have a substantial effect on IQ without treatment.
Furthermore, the screening was done at approximately
12 weeks of gestation, which is around the time the fetus
should start producing its own thyroid hormones, and
this could be simply too late to have a measurable effect.
Although they do not settle this argument once and for
all, these data currently do not support population
screening for hypothyroidism during pregnancy.
Lazarus et al. (2012) NEJM 366, 493–501.
Y I Have Heart Disease
The Y chromosome is the key to ‘‘maleness,’’ and men are
at a higher risk of developing heart disease than are
women. Is this simply a product of male biology, or is there
something on the Y chromosome itself that influences this
risk? This is the question explored by Charchar et al. in
a recent study. They used data from two large studies to
assess the association between Y chromosome hap-
logroups and the risk of heart disease. They found that
haplogroup I—the second most common haplogroup in
their population—was associated with a ~50% increase in
risk of coronary artery disease compared to the other
haplogroups, and this association is independent of tradi-
tional cardiovascular risk factors. Transcriptome analyses
in macrophages highlight pathways of genes involved in1Department of Human Genetics, Emory University School of Medicine, Atlan
*Correspondence: kgarber@genetics.emory.edu
DOI 10.1016/j.ajhg.2012.02.016. 2012 by The American Society of Human
The Ameimmunity and inflammation; these pathways are differen-
tially expressed in men with haplogroup I, which perhaps
has relevance for the development of cardiovascular
disease. Although not particularly predictive of heart
disease on an individual basis, this haplogroup was found
in ~15% of men in British samples and could contribute
substantially to the risk of developing heart disease in
the overall population.
Charchar et al. (2012) Lancet. Published online February 9,
2012. 10.1016/S0140-6736(11)61453-0.
Uncovering the Pathways Involved in Behavioral
Aspects of MECP2 Duplication
In order to study the association between anxiety,
autism, and duplications of chromosome X28, Samaco
et al. recently made transgenic mouse strains that express
increased levels of MECP2, one of the two genes in the
minimal duplicated region. Mirroring what is observed in
people with these duplications, mice that express two or
three times the normal level of MeCP2 exhibit anxiety-
like behavior and have deficits in social interaction. They
also have alterations in the expression of genes, including
Crh and Oprm1, that have previously been associated with
anxiety-like behaviors. These changes in gene expression
are central to the behavioral phenotypes in mice overex-
pressing MeCP2; if these mice express less Crh, their
anxiety behaviors are improved, and if they express less
Oprm1, their social behavior is improved. A pharmacolog-
ical antagonist of the Crh receptor also improves anxiety
in this mouse model, which provides some hope that
manipulations to this pathway in people could moderate
the behavioral features resulting from this genomic dupli-
cation.
Samaco et al. (2012) Nat Genet. 44, 206–211.
An –ome for Mitochondrial Disease
The common link among the so-called mitochondrial
disorders is a defect in this organelle’s main job, oxidative
phosphorylation. Despite this defined functional defect,
diagnosing mitochondrial disorders can be difficult
because biochemical test results can be equivocal, and
they require a muscle biopsy. Although molecular diag-
nosis can avoid these issues, there are more than 100
relevant nuclear genes beyond those found in the mito-
chondrial DNA (mtDNA), and such a high number makes
it challenging to find the single gene that is mutated inta, GA 30322, USA
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a particular patient. In fact, the relevant mutation is iden-
tified in a minority of cases. Calvo et al. turned to a tar-
geted capture and next-generation-sequencing approach
to address this problem. Their MitoExome sequencing
covers the complete mitochondrial genome, as well as
more than 1,000 nuclear genes that are believed to
encode mitochondrial proteins. They tested their
approach on 42 infants with clinical and biochemical
evidence of a defect in oxidative phosphorylation. Of
these, one patient had a large deletion in the mtDNA,
ten had recessive mutations in eight genes that were
already known to cause mitochondrial disease, and 13
had putative mutations in novel disease-associated genes.
Of the genes in this last category, further data supported
their classification as novel mitochondrial disease-associ-
ated genes in two cases (so far); mutations in AGK were
found in two unrelated patients with a similar phenotype,
whereas mutations in NDUFB3 were supported via
complementation studies of mitochondrial function.
Thus, although this type of approach might ultimately
facilitate the diagnosis of mitochondrial disease, muta-
tions were not found in a significant portion of patients
in this sample. Proving causation for those patients that
had putative mutations would require additional func-
tional studies, which would be challenging in a clinical
diagnostic setting.
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Results
Newborn screening (NBS) results from tandem mass spec-
trometry are typically assessed through the window of
a series of analyte cut-off values that are set by each lab
for each disorder screened. Although designed to maxi-
mize the number of affected babies that are detected, this
discrete cut-off approach yields a number of false positives
and false negatives. Is there a better way to analyze the
same screening data? Marquard et al. attempted to do
just this as a component of the Region 4 project of the
Regional Genetics and Newborn Screening Collaboratives.
Using data from more than 150 laboratories from across
the world, they developed pattern-recognition software
that integrates information from metabolic profiles,
compares them to a database of values measured in cases
and controls, and generates a single score for each disorder
that can be compared to a set of interpretation guidelines.
Retrospective analysis suggests that this would reduce the
number of false-positive results in carriers of the relevant
conditions by at least half and could avoid 88% of false
negatives. This predicted improvement was borne out by
the use of these tools in Minnesota’s newborn-screening
program, which has achieved a false-positive rate of
0.05% and a positive predictive value of over 60%.
Marquard et al. (2012) Genet Med. Published online
February 16, 2012. 10.1038/gim.2012.2.This Month in Our Sister JournalsA Most Severe Bottleneck
More than one sequence-based study has estimated that
a single HIV-1 genome is transferred between partners
during sexual transmission of the virus. Starting with
a population size of one, it is hard to conceive how the
virus exhibits the rapid adaptation that is observed during
the early phase of infection. Da Silva recently modeled
early HIV infection and found that the severe population
bottleneck that occurs at sexual transmission is compatiblewith the adaptive capabilities of the virus in early infec-
tion. This assumes strong selection by CD8þ T cells that
wanes over time. This severe reduction in effective popula-
tion size also suggests that mutations do not tend to hitch-
hike with each other but that this mutational interference
becomes more prevalent as the population size increases
and the CD8þ T cell –mediated selection weakens.
Da Silva. (2011) Genetics. Published online December 29,
2011. 10.1534/genetics.111.136366., 2012
